Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22270258 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sorafenib for Imatinib/Sunitinib-failed GIST
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Sorafenib

Study has passed its completion date and status has not been verified in more than two years.